CARILLON TOWER ADVISERS, INC. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 241 filers reported holding NOVOCURE LTD in Q3 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
CARILLON TOWER ADVISERS, INC. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q4 2020$53,754,000
+520.0%
310,642
+298.8%
0.33%
+181.9%
Q3 2020$8,670,000
-100.0%
77,894
-86.4%
0.12%
-68.0%
Q1 2020$36,949,314,000
-23.4%
572,6800.0%0.36%
+12.4%
Q4 2019$48,259,744,000
+112590.6%
572,6800.0%0.32%
+8.1%
Q3 2019$42,825,000572,6800.30%
Other shareholders
NOVOCURE LTD shareholders Q3 2019
NameSharesValueWeighting ↓
StepStone Group LP 1,365,479$29,767,00021.90%
Tamarack Advisers, LP 1,115,000$24,307,00011.56%
COURAGE CAPITAL MANAGEMENT LLC 275,000$5,995,0004.57%
GREAT POINT PARTNERS LLC 753,481$16,426,000,0002.44%
HARTLINE INVESTMENT CORP/ 404,052$8,808,0002.42%
Pier Capital, LLC 346,350$7,550,0001.29%
Rhenman & Partners Asset Management AB 435,000$9,483,0001.17%
HIGHLINE CAPITAL MANAGEMENT, L.P. 1,029,910$22,452,0000.77%
PEREGRINE CAPITAL MANAGEMENT LLC 922,468$20,110,0000.49%
Hodges Capital Management Inc. 285,500$6,224,0000.49%
View complete list of NOVOCURE LTD shareholders